These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 17866361)
61. THE USE OF BACILLUS WELCHII (PERFRINGENS) ANTITOXIN IN EXPERIMENTAL GENERAL PERITONITIS AND INTESTINAL OBSTRUCTION. Copher GH; Stone CS; Hildreth HR Ann Surg; 1929 May; 89(5):641-6. PubMed ID: 17866091 [No Abstract] [Full Text] [Related]
62. [Comparative evaluation of the methods of determining perfringens A antitoxin]. Shemanova GF; Trapezov EV; Musina EE; Vlasova EV; Panteleev EI Biull Eksp Biol Med; 1983 Nov; 96(11):82-4. PubMed ID: 6315110 [TBL] [Abstract][Full Text] [Related]
63. FIFTH INTERNATIONAL STANDARD FOR GAS-GANGRENE ANTITOXIN (PERFRINGENS) (CLOSTRIDIUM WELCHII TYPE A ANTITOXIN). EVANS DG; PERKINS FT Bull World Health Organ; 1963; 29(6):729-35. PubMed ID: 14107745 [TBL] [Abstract][Full Text] [Related]
64. Combined therapy with gas gangrene antitoxin and recombinant human soluble thrombomodulin for Clostridium perfringens sepsis in a rat model. Hifumi T; Nakano D; Chiba J; Takahashi M; Yamamoto A; Fujisawa Y; Kawakita K; Kuroda Y; Nishiyama A Toxicon; 2018 Jan; 141():112-117. PubMed ID: 29246581 [TBL] [Abstract][Full Text] [Related]
65. THE ROLE OF THE BACILLUS WELCHII IN ACUTE INTESTINAL OBSTRUCTION: WITH LIGATION OF THE VEINS TO THE OBSTRUCTED LOOP. McIver MA; White JC; Lawson GM Ann Surg; 1929 May; 89(5):647-57. PubMed ID: 17866092 [No Abstract] [Full Text] [Related]
66. THE USE OF PERFRINGENS ANTITOXIN IN INTESTINAL OBSTRUCTION: AN EXPERIMENTAL STUDY. North JP Ann Surg; 1930 Aug; 92(2):277-80. PubMed ID: 17866361 [No Abstract] [Full Text] [Related]
67. Predisposing factors and prevention of Clostridium perfringens-associated enteritis. Allaart JG; van Asten AJ; Gröne A Comp Immunol Microbiol Infect Dis; 2013 Sep; 36(5):449-64. PubMed ID: 23790636 [TBL] [Abstract][Full Text] [Related]